Canaccord Genuity Reiterates a 'Buy' on Brightpoint (CELL); Upbeat Meeting at MWC: Strong Pipeline and Trends for 2012
Tweet Send to a Friend
Canaccord Genuity reiterates a 'Buy' on Brightpoint (NASDAQ: CELL), PT $14.
Canaccord analyst says, "We met with Brightpoint’s CEO Bob ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst says, "We met with Brightpoint’s CEO Bob ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
